Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when AGL files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: AGL agilon health, inc. 8-K

agilon health holds routine annual meeting; directors elected, auditor and pay approved

Filed June 3, 2026 · Period ending June 2, 2026 · ~1 min read

3 key changes 1 section

Key Changes

  • low

    Three Class II directors elected to serve until 2029: Diana McKenzie (strongest support), Karen McLoughlin, and Ronald Williams. All received majority shareholder approval.

  • low

    Ernst & Young LLP ratified as independent auditor for 2026 with 99.8% approval (13.7M votes for vs. 6,616 against).

  • low

    Executive compensation approved on advisory basis with 95% support (11.2M for, 628K against), indicating shareholder satisfaction with pay practices.

Summary

agilon health held its annual stockholder meeting on June 2, 2026, completing standard corporate governance procedures. The company successfully elected three Class II directors to three-year terms, ratified its auditor, and received shareholder approval for executive compensation. All votes passed with strong majorities, suggesting no significant shareholder dissent on governance matters.

For retail investors, this filing is purely procedural with no material business impact. The strong approval rates across all proposals indicate alignment between management and shareholders on board composition and compensation practices. The next item to watch would be the company's quarterly earnings report or any strategic announcements, as this 8-K contains no operational or financial updates.

Section-by-Section Diff

Event · Item 5.07 — Submission of Matters to a Vote of Security Holders

~300 words

Annual meeting held June 2, 2026: three Class II directors elected, auditor ratified, executive compensation approved on advisory basis.

1 Added
Show 1 minor / wording change
Added Director elections low

Added in current filing · verify on EDGAR →

The following three individuals were elected to the Company's Board of Directors to serve as Class II directors until the Company's 2029 annual meeting of stockholders and until their successors have been duly elected and qualified. Name Votes | For | Votes | Against | Votes | Abstained | Broker | Non-Votes Diana McKenzie 11,679,958177,7607,0341,870,677 Karen McLoughlin 9,525,4912,332,2087,0531,870,677 Ronald Williams 10,837,6231,019,3477,7821,870,677

Three Class II directors were elected at the annual meeting: Diana McKenzie, Karen McLoughlin, and Ronald Williams. All three received majority support and will serve until the 2029 annual meeting. McKenzie received the strongest support with 11.7 million votes for, while McLoughlin had the most opposition with 2.3 million votes against.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify